Name:	kim_Note15FairValueDisclosureofFinancialInstrumentsDetailsLineItems
Namespace Prefix:	kim_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=8077374&loc=d3e2420-110228

+ Details

Name:	us-gaap_AssetImpairmentCharges
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

This element represents the aggregate of the assets reported on the balance sheet at period end measured at fair value on a nonrecurring basis by the entity. This element is intended to be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements.

+ References

No definition available.

+ Details

Name:	us-gaap_AssetsFairValueDisclosureNonrecurring
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 35

-Paragraph 32

-URI http://asc.fasb.org/extlink&oid=7658923&loc=d3e32787-111569

+ Details

Name:	us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Ratio of the net operating income produced by an asset and its capital cost (original prices paid to buy the asset), used as an input to measure fair value.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (bbb)

-URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258

+ Details

Name:	us-gaap_FairValueInputsCapRate
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure fair value. For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt.

+ References

+ Details

Name:	us-gaap_FairValueInputsDiscountRate
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The charge against earnings in the period to reduce the carrying amount of real property to fair value.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2921-110230

+ Details

Name:	us-gaap_ImpairmentOfRealEstate
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Total debt and equity financial instruments including: (1) securities held-to-maturity, (2) trading securities, and (3) securities available-for-sale.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.4)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 5

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27232-111563

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563

+ Details

Name:	us-gaap_MarketableSecurities
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

Note 15 - Fair Value Disclosure of Financial Instruments (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Note 15 - Fair Value Disclosure of Financial Instruments (Details) [Line Items]
Marketable Securities	$ 62,766,000	$ 36,541,000
Asset Impairment Charges	190,218,000	59,569,000	32,763,000
Impairment of Real Estate	59,600,000
Fair Value Inputs, Cap Rate	6.00%
Fair Value Inputs, Discount Rate	9.50%
Cost-method Investments [Member]
Note 15 - Fair Value Disclosure of Financial Instruments (Details) [Line Items]
Asset Impairment Charges	10,400,000
Other Joint Venture Programs [Member]
Note 15 - Fair Value Disclosure of Financial Instruments (Details) [Line Items]
Equity Method Investment, Other than Temporary Impairment	1,000,000
Preferred Equity Capital [Member]
Note 15 - Fair Value Disclosure of Financial Instruments (Details) [Line Items]
Equity Method Investment, Other than Temporary Impairment	3,200,000
Fair Value, Estimate Not Practicable, Carrying (Reported) Amount [Member]
Note 15 - Fair Value Disclosure of Financial Instruments (Details) [Line Items]
Impairment of Real Estate	175,600,000
Discontinued Operations [Member]
Note 15 - Fair Value Disclosure of Financial Instruments (Details) [Line Items]
Asset Impairment Charges	98,800,000
Impairment of Real Estate	49,300,000
Fair Value, Inputs, Level 1 [Member]
Note 15 - Fair Value Disclosure of Financial Instruments (Details) [Line Items]
Marketable Securities	59,700,000
Fair Value, Inputs, Level 3 [Member]
Note 15 - Fair Value Disclosure of Financial Instruments (Details) [Line Items]
Marketable Securities	3,100,000
Minimum [Member]
Note 15 - Fair Value Disclosure of Financial Instruments (Details) [Line Items]
Assets, Fair Value Disclosure, Nonrecurring		1,100,000
Maximum [Member]
Note 15 - Fair Value Disclosure of Financial Instruments (Details) [Line Items]
Assets, Fair Value Disclosure, Nonrecurring		$ 42,000,000